Literature DB >> 19597414

An in vitro skin irritation test (SIT) using the EpiDerm reconstructed human epidermal (RHE) model.

Helena Kandárová1, Patrick Hayden, Mitchell Klausner, Joseph Kubilus, John Sheasgreen.   

Abstract

The EpiDerm Skin Irritation test (EpiDerm SIT) was developed and validated for in vitro skin irritation testing of chemicals, including cosmetic and pharmaceutical ingredients. The EpiDerm SIT utilizes the 3D in vitro reconstructed human epidermal (RHE) model EpiDerm. The procedure described in this protocol allows for discrimination between irritants of GHS category 2 and non-irritants. The test is performed over the course of a 4 day time period, consisting of pre-incubation, 60 minute exposure, 42 hour post-incubation and MTT viability assay. After tissue receipt and overnight pre-incubation (Day 0), tissues are topically exposed to the test chemicals (Day 1), which can be liquid, semisolid, solid or waxy. Three tissues are used for each test chemical, as well as for the positive control (5% aq. SDS solution), and a negative control (DPBS). Chemical exposure lasts for 60 minutes, 35 min of which the tissues are kept in an incubator at 37 degrees C. The test substances are then removed from the tissue surface by an extensive washing procedure. The tissue inserts are blotted and transferred to fresh medium. After a 24 hr incubation period (Day 2), the medium is exchanged. The medium can be saved for further analysis of cytokines or other endpoints of interest. After the medium exchange, tissues are incubated for an additional 18 hours. At the end of the entire 42 h post-incubation (day 3), the tissues are transferred into yellow MTT solution and incubated for 3 hours. The resultant purple-blue formazan salt, formed mainly by mitochondrial metabolism, is extracted for 2 hours using isopropanol. The optical density of the extracted formazan is determined using a spectrophotometer. A chemical is classified as an irritant if the tissue viability relative to the negative control treated tissues is reduced below 50%. This procedure can be used as full replacement of the in vivo rabbit skin irritation test for hazard identification and labeling of chemicals in line with EU regulations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597414      PMCID: PMC3253670          DOI: 10.3791/1366

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  6 in total

1.  Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests.

Authors:  Helena Kandárová; Manfred Liebsch; Elke Genschow; Ingrid Gerner; Dieter Traue; Birgitta Slawik; Horst Spielmann
Journal:  ALTEX       Date:  2004       Impact factor: 6.043

2.  The EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests--an assessment of the performance of the optimised test.

Authors:  Helena Kandárová; Manfred Liebsch; Ingrid Gerner; Elisabeth Schmidt; Elke Genschow; Dieter Traue; Horst Spielmann
Journal:  Altern Lab Anim       Date:  2005-08       Impact factor: 1.303

3.  Ensuring quality of in vitro alternative test methods: issues and answers.

Authors:  Kailash Gupta; Amy Rispin; Katherine Stitzel; Sandra Coecke; John Harbell
Journal:  Regul Toxicol Pharmacol       Date:  2005-08-15       Impact factor: 3.271

Review 4.  Ensuring quality of in vitro alternative test methods: Current practice.

Authors:  Amy Rispin; Katherine Stitzel; John Harbell; Mitchell Klausner
Journal:  Regul Toxicol Pharmacol       Date:  2006-04-27       Impact factor: 3.271

5.  In vitro skin irritation testing: Improving the sensitivity of the EpiDerm skin irritation test protocol.

Authors:  Helena Kandárová; Patrick Hayden; Mitch Klausner; Joseph Kubilus; Paul Kearney; John Sheasgreen
Journal:  Altern Lab Anim       Date:  2009-12       Impact factor: 1.303

6.  The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test.

Authors:  Horst Spielmann; Sebastian Hoffmann; Manfred Liebsch; Phil Botham; Julia H Fentem; Chantra Eskes; Roland Roguet; José Cotovio; Thomas Cole; Andrew Worth; Jon Heylings; Penny Jones; Catherine Robles; Helena Kandárová; Armin Gamer; Marina Remmele; Rodger Curren; Hans Raabe; Amanda Cockshott; Ingrid Gerner; Valérie Zuang
Journal:  Altern Lab Anim       Date:  2007-12       Impact factor: 1.303

  6 in total
  13 in total

1.  Scrolls: novel microparticulate systems for enhanced delivery to/across the skin.

Authors:  Irit Allon; Elka Touitou
Journal:  Drug Deliv Transl Res       Date:  2016-02       Impact factor: 4.617

2.  Enhanced skin delivery of vismodegib by microneedle treatment.

Authors:  Hiep X Nguyen; Ajay K Banga
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

3.  Pouch drug delivery systems for dermal and transdermal administration.

Authors:  Jana Zailer; Elka Touitou
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

4.  Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride.

Authors:  Jaclyn M Hosmer; Alexandre A Steiner; Luciana B Lopes
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

5.  Xanthophylls lutein and zeaxanthin modify gene expression and induce synthesis of hyaluronan in keratinocyte model of human skin.

Authors:  Rasia Li; Stephen D Turner; David L Brautigan
Journal:  Biochem Biophys Rep       Date:  2015-08-21

6.  Investigation of the Dermal Absorption and Irritation Potential of Sertaconazole Nitrate Anhydrous Gel.

Authors:  Mahima Manian; Kumpal Madrasi; Ayyappa Chaturvedula; Ajay K Banga
Journal:  Pharmaceutics       Date:  2016-07-07       Impact factor: 6.321

7.  New lupeol esters as active substances in the treatment of skin damage.

Authors:  Magdalena Malinowska; Barbara Miroslaw; Elzbieta Sikora; Jan Ogonowski; Agnieszka M Wojtkiewicz; Maciej Szaleniec; Monika Pasikowska-Piwko; Irena Eris
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

8.  Skin Irritation Testing beyond Tissue Viability: Fucoxanthin Effects on Inflammation, Homeostasis, and Metabolism.

Authors:  Renata Spagolla Napoleão Tavares; Silvya Stuchi Maria-Engler; Pio Colepicolo; Hosana Maria Debonsi; Monika Schäfer-Korting; Uwe Marx; Lorena Rigo Gaspar; Christian Zoschke
Journal:  Pharmaceutics       Date:  2020-02-05       Impact factor: 6.321

9.  Overcoming the cutaneous barrier with microemulsions.

Authors:  Luciana B Lopes
Journal:  Pharmaceutics       Date:  2014-02-28       Impact factor: 6.321

10.  Dual-functional transdermal drug delivery system with controllable drug loading based on thermosensitive poloxamer hydrogel for atopic dermatitis treatment.

Authors:  Wenyi Wang; Elaine Wat; Patrick C L Hui; Ben Chan; Frency S F Ng; Chi-Wai Kan; Xiaowen Wang; Huawen Hu; Eric C W Wong; Clara B S Lau; Ping-Chung Leung
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.